RobertGaryFentonMD

Oncology • Falls Church, VA

Physician

Join to view full profile

Are you Dr. Fenton?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
6400 Arlington Blvd
Ste 940
Falls Church, VA 22042
Phone+1 240-447-2512

Fax+1 703-241-7723

Summary

Dr. Robert Fenton, MD is an oncologist in Falls Church, Virginia. He is currently licensed to practice medicine in Maryland.

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1989
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1987
Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1985
New York University School of MedicineClass of 1983

Certifications & Licensure

MD State Medical License 1989 - 2012

Publications & Presentations

PubMed

174 citations
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Ashraf Badros, Olga Goloubeva, Jay S. Dalal, Ilyas Can, Jennifer Thompson
Cancer. 2007-09-01
30 citations
Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.
Ashraf Badros, Olga Goloubeva, Robert G. Fenton, Aaron P. Rapoport, Gorgun Akpek
Clinical Lymphoma & Myeloma. 2006-11-01
6 citations
Flavopiridol in patients with relapsed or refractory multiple myeloma: a phase 2 trial with clinical and pharmacodynamic end-points.
Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Susan M Geyer, Tom R Fitch
Haematologica. 2006-03-01

Press Mentions

Urine Concentration Ability Is Reduced to the Same Degree in Adult Dominant Polycystic Kidney Disease Compared with Other Chronic Kidney Diseases in the Same CKD-Stage and Lower THAN in Healthy Control Subjects - a CASE Control StudyAugust 31st, 2020